Bio-orthogonal targeted cascade co-delivery of CRISPR-Cas9 RNP and paclitaxel for synergistic gene editing and chemotherapy
Chemical Engineering Journal · 2026-12 · 549 · 182285
DOI: 10.1016/j.cej.2026.182285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Engineering Journal, 2026-12. Verfasst von Shuang Liu und 13 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, S., Deng, S., Ouyang, S., Yuan, J., Ou, C., Zheng, J., Hao, C., Yu, D., Wang, J., Liu, J., Kim, H., Zhang, Z., Li, M., & Cheng, D. (2026). Bio-orthogonal targeted cascade co-delivery of CRISPR-Cas9 RNP and paclitaxel for synergistic gene editing and chemotherapy. Chemical Engineering Journal, 549, 182285. https://doi.org/10.1016/j.cej.2026.182285
Vancouver
Liu S, Deng S, Ouyang S, Yuan J, Ou C, Zheng J, et al. Bio-orthogonal targeted cascade co-delivery of CRISPR-Cas9 RNP and paclitaxel for synergistic gene editing and chemotherapy. Chemical Engineering Journal. 2026;549:182285. doi:10.1016/j.cej.2026.182285
BibTeX
@article{Liu2026,
author = {Liu, Shuang and Deng, Shaohui and Ouyang, Siyu and Yuan, Jianming and Ou, Chiyi and Zheng, JiaoJiao and Hao, Chenhui and Yu, Dongsheng and Wang, Jin and Liu, Jun-min and Kim, Hae-Won and Zhang, Zhen and Li, Mingqiang and Cheng, Du},
title = {Bio-orthogonal targeted cascade co-delivery of CRISPR-Cas9 RNP and paclitaxel for synergistic gene editing and chemotherapy},
journal = {Chemical Engineering Journal},
year = {2026},
volume = {549},
pages = {182285},
doi = {10.1016/j.cej.2026.182285}
}
EUVIMED